Skip to main content
. 2022 Jun 10;12:893294. doi: 10.3389/fcimb.2022.893294

Table 1.

Comparison of clinical and laboratory findings among patients, with and without SAP (training sample set).

Variable Training set (n = 487) Test set (n = 161) P-value
Age, years (IQR) 47 (37,61) 49 (36,64) 0.501
Male sex, N (%) 301 (61.81) 103 (63.98) 0.623
Duration of symptoms (days, IQR) 1.83 ± 0.80 1.78 ± 0.78 0.515
BMI, kg/m2 (IQR) 23.5 (21.1-26.3) 23.9 (21.5-21.5) 0.573
SIRS, N (%) 191 (39.22) 65 (40.37) 0.795
Biliary etiology, N (%) 207 (42.51) 68 (42.24) 0.584
Laboratory findings
Hematocrit (l/l) 0.42 (0.38-0.46) 0.42 (0.38-0.46) 0.693
Platelets (109/L) 199 (161-233) 195 (157-233) 0.472
Prothrombin time, s (IQR) 13.8 (13.1-14.6) 13.7 (13.0-14.5) 0.278
Albumin, g/L (IQR) 36.3 (32.6-39.9) 36.4 (34.0-39.8) 0.191
Total bilirubin, mmol/L (IQR) 20 (14-31) 20 (13-32) 0.916
ALT, U/L (IQR) 43 (19-119) 31 (19-82) 0.055
AST, U/L (IQR) 39 (22-88) 28 (19-71) 0.012
Glucose, mmol/L (IQR) 7.9 (6.3-10.5) 8.4 (6.7-11.3) 0.128
Serum creatinine, μmol/L (IQR) 64 (54-77) 64 (55-76) 0.882
BUN, mmol/L (IQR) 4.8 (3.7-6.1) 4.9 (4.0-6.2) 0.346
Total cholesterol, mmol/L (IQR) 4.79 (3.8-6.2) 4.8 (3.8-6.1) 0.970
HDL, mmol/L (IQR) 1.0 (0.7-1.3) 1.0 (0.8-1.3) 0.461
LDL, mmol/L (IQR) 2.5 (1.9-3.2) 2.2 (1.8-3.0) 0.100
Triglyceride (mg/dL), mmol/L (IQR) 1.3 (0.8-3.4) 1.3 (0.8-3.6) 0.995
Serum calcium, mmol/L (IQR) 2.7 (2.1-2.3) 2.2 (2.1-2.3) 0.051
C-reactive protein, mg/L (IQR) 35.0 (11.7-90.0) 29.4 (8.7-85.3) 0.415
Pleural effusion, N (%) 89 (18.28) 35 (21.74) 0.333
Patients with SAP, N (%) 49 (10.1) 16 (9.9) 0.0092
Length of hospital stay, days (IQR) 10 (7-13) 11 (7-15) 0.964
Hospital mortality, N (%) 9 (1.85) 1 (0.62) 0.274

Data were mean ± standard deviation, or numbers and percentages, or median (25th–75th percentile), as appropriate. N, number; IQR, interquartile range; BMI, body mass index; SIRS, systemic inflammatory response syndrome; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.